These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Detection of BRAF c.1799T > A (p.V600E) mutation using residual routine fine-needle aspiration specimens of papillary thyroid carcinoma. Zhao H, Zhang ZH, Zhou B, Xiao T, Pan QJ, Guo HQ. Diagn Cytopathol; 2015 Oct; 43(10):786-90. PubMed ID: 26152656 [Abstract] [Full Text] [Related]
3. False-negative BRAF V600E mutation results on fine-needle aspiration cytology of papillary thyroid carcinoma. Paek SH, Kim BS, Kang KH, Kim HS. World J Surg Oncol; 2017 Nov 13; 15(1):202. PubMed ID: 29132392 [Abstract] [Full Text] [Related]
4. Utility of BRAF mutation detection in fine-needle aspiration biopsy samples read as "suspicious for papillary thyroid carcinoma". Jara SM, Bhatnagar R, Guan H, Gocke CD, Ali SZ, Tufano RP. Head Neck; 2015 Dec 13; 37(12):1788-93. PubMed ID: 24989827 [Abstract] [Full Text] [Related]
5. Detection of the BRAF(V600E) mutation in fine needle aspiration cytology of thyroid papillary microcarcinoma cells selected by manual macrodissection: an easy tool to improve the preoperative diagnosis. Marchetti I, Iervasi G, Mazzanti CM, Lessi F, Tomei S, Naccarato AG, Aretini P, Alberti B, Di Coscio G, Bevilacqua G. Thyroid; 2012 Mar 13; 22(3):292-8. PubMed ID: 22181337 [Abstract] [Full Text] [Related]
6. A morpho-molecular diagnosis of papillary thyroid carcinoma: BRAF V600E detection as an important tool in preoperative evaluation of fine-needle aspirates. Marchetti I, Lessi F, Mazzanti CM, Bertacca G, Elisei R, Coscio GD, Pinchera A, Bevilacqua G. Thyroid; 2009 Aug 13; 19(8):837-42. PubMed ID: 19534623 [Abstract] [Full Text] [Related]
7. Molecular characterization of 54 cases of false-negative fine-needle aspiration among 1347 papillary thyroid carcinomas. Proietti A, Borrelli N, Giannini R, Romani R, Di Coscio G, Quilici F, Rago T, Miccoli P, Vitti P, Basolo F. Cancer Cytopathol; 2014 Oct 13; 122(10):751-9. PubMed ID: 24913568 [Abstract] [Full Text] [Related]
9. Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: New insights. Rossi ED, Martini M, Bizzarro T, Capodimonti S, Cenci T, Lombardi CP, Pontecorvi A, Fadda G, Larocca LM. Cancer Cytopathol; 2015 Oct 13; 123(10):593-602. PubMed ID: 26230187 [Abstract] [Full Text] [Related]
10. Preoperative cytology with molecular analysis to help guide surgery for pediatric thyroid nodules. Buryk MA, Monaco SE, Witchel SF, Mehta DK, Gurtunca N, Nikiforov YE, Simons JP. Int J Pediatr Otorhinolaryngol; 2013 Oct 13; 77(10):1697-700. PubMed ID: 23993207 [Abstract] [Full Text] [Related]
11. Surgical results of thyroid nodules according to a management guideline based on the BRAF(V600E) mutation status. Kim SK, Hwang TS, Yoo YB, Han HS, Kim DL, Song KH, Lim SD, Kim WS, Paik NS. J Clin Endocrinol Metab; 2011 Mar 13; 96(3):658-64. PubMed ID: 21239517 [Abstract] [Full Text] [Related]
12. Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent area. Chung KW, Yang SK, Lee GK, Kim EY, Kwon S, Lee SH, Park DJ, Lee HS, Cho BY, Lee ES, Kim SW. Clin Endocrinol (Oxf); 2006 Nov 13; 65(5):660-6. PubMed ID: 17054470 [Abstract] [Full Text] [Related]
13. Diagnostic value of BRAF(V600E) mutation analysis of thyroid nodules according to ultrasonographic features and the time of aspiration. Moon HJ, Kim EK, Chung WY, Choi JR, Yoon JH, Kwak JY. Ann Surg Oncol; 2011 Mar 13; 18(3):792-9. PubMed ID: 20945104 [Abstract] [Full Text] [Related]
14. Role of ultrasonographic/clinical profile, cytology, and BRAF V600E mutation evaluation in thyroid nodule screening for malignancy: a prospective study. Rossi M, Buratto M, Bruni S, Filieri C, Tagliati F, Trasforini G, Rossi R, Beccati MD, Degli Uberti EC, Zatelli MC. J Clin Endocrinol Metab; 2012 Jul 13; 97(7):2354-61. PubMed ID: 22535974 [Abstract] [Full Text] [Related]
15. Cytomorphologic features in thyroid nodules read as "suspicious for malignancy" on cytology may predict thyroid cancers with the BRAF mutation. Kwon HJ, Kim EK, Kwak JY. Pathol Res Pract; 2015 Sep 13; 211(9):671-6. PubMed ID: 26187369 [Abstract] [Full Text] [Related]
16. Allele-specific PCR with competitive probe blocking for sensitive and specific detection of BRAF V600E in thyroid fine-needle aspiration specimens. Smith GD, Zhou L, Rowe LR, Jarboe EA, Collins BT, Bentz JS, Wittwer CT, Chadwick BE. Acta Cytol; 2011 Sep 13; 55(6):576-83. PubMed ID: 22156469 [Abstract] [Full Text] [Related]
17. [BRAF V600E mutation in papillary thyroid carcinoma: prevalence and detection in fine needle aspiration specimens]. Dujardin F, Pagès JC, Collin C, de Calan L, Lecomte P, Guyétant S. Ann Pathol; 2010 Aug 13; 30(4):252-62. PubMed ID: 20837233 [Abstract] [Full Text] [Related]
18. Pilot of BRAF mutation analysis in indeterminate, suspicious and malignant thyroid FNA cytology. Johnson SJ, Hardy SA, Roberts C, Bourn D, Mallick U, Perros P. Cytopathology; 2014 Jun 13; 25(3):146-54. PubMed ID: 24417615 [Abstract] [Full Text] [Related]
20. Clinical implication of highly sensitive detection of the BRAF V600E mutation in fine-needle aspirations of thyroid nodules: a comparative analysis of three molecular assays in 4585 consecutive cases in a BRAF V600E mutation-prevalent area. Lee ST, Kim SW, Ki CS, Jang JH, Shin JH, Oh YL, Kim JW, Chung JH. J Clin Endocrinol Metab; 2012 Jul 13; 97(7):2299-306. PubMed ID: 22500044 [Abstract] [Full Text] [Related] Page: [Next] [New Search]